Sekhmet Pharmaventures is a Manufacturer/Innovator, CMO/CDMO company operating in the pharmaceutical industry.
Gamot API is the holding company of Sekhmet Pharmaventures Pvt. Ltd. Asian private equity major PAG has formed an investment platform called Gamot API Pte. Ltd. based in Singapore, along with Indian private equity firms, CX Partners and Samara Capital, to buy stakes in fast-growing Indian pharma companies. The Indian subsidiary of Gamot API is known as Sekhmet Pharmaventures Pvt. Ltd. Sekhmet Pharmaventures has acquired major stake in Chennai-based Anjan Drug Pvt. Ltd. in October 2020. Subsequently, Sekhmet Pharmaventures acquired major stake in Optimus Drugs Group of Companies in May 2022.
Company type
Manufacturer/Innovator, CMO/CDMO
Products and services
Custom Manufacturing, Intermediates, Fine and Specialty Chemicals, Pharmaceutical Machinery & Technology
Markets
North America (USA, Canada), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Useful Links
Connect with Sekhmet Pharmaventures on LinkedIn
Address
Sekhmet Pharmaventures, 2nd Floor, Sy No. 37/A & 37/P, Plot No.6P, Signature Towers, Kothaguda, Kondapur, Hyderabad, Gujarat, India, 500 084
